![EA3202 for Advanced Head and Neck Cancer](https://oncodaily.com/pub/uploads/2024/07/GSik06IXYAAKSrP-1280x720.jpg)
Photo from ECOG-ACRIN Cancer Research Group/X
Jul 17, 2024, 05:32
EA3202 for Advanced Head and Neck Cancer
ECOG-ACRIN Cancer Research Group shared a post on X:
“Clinical Trial EA3202, led by Aarti Bhatia of Yale Cancer Center, aims to improve results for patients with advanced-stage Head and Neck Cancer by comparing several treatment approaches. Learn more.” .
Source: ECOG-ACRIN/X
Jul 17, 2024, 04:19